Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$137M Sell
1,162,165
-26,179
-2% -$3.02M 0.2% 92
2026
Q1
$142M Buy
1,188,344
+447,031
+60% +$58.6M 0.24% 75
2025
Q4
$101M Buy
741,313
+273,912
+59% +$39.4M 0.17% 113
2025
Q3
$68.9M Sell
467,401
-33,467
-7% -$4.64M 0.13% 156
2025
Q2
$64.8M Sell
500,868
-133,363
-21% -$16.2M 0.13% 154
2025
Q1
$75.8M Buy
634,231
+59,904
+10% +$7.42M 0.18% 122
2024
Q4
$66.6M Sell
574,327
-9,061
-2% -$1.15M 0.17% 123
2024
Q3
$78.8M Buy
583,388
+7,842
+1% +$1.05M 0.2% 106
2024
Q2
$78.1M Buy
575,546
+54,582
+10% +$7.43M 0.22% 91
2024
Q1
$67.3M Sell
520,964
-26,964
-5% -$3.26M 0.22% 87
2023
Q4
$62.7M Buy
547,928
+21,536
+4% +$2.15M 0.22% 88
2023
Q3
$47.9M Buy
526,392
+88,987
+20% +$9.18M 0.2% 93
2023
Q2
$49.3M Sell
437,405
-56,780
-11% -$6M 0.2% 94
2023
Q1
$51.7M Buy
494,185
+20,602
+4% +$2.15M 0.23% 85
2022
Q4
$52.4M Buy
473,583
+91,335
+24% +$9.57M 0.26% 72
2022
Q3
$33.4M Buy
382,248
+11,121
+3% +$1.01M 0.19% 109
2022
Q2
$29M Buy
371,127
+78,155
+27% +$6.45M 0.15% 146
2022
Q1
$25M Buy
292,972
+56,010
+24% +$5.37M 0.12% 182
2021
Q4
$28.4M Buy
236,962
+69,585
+42% +$8.64M 0.12% 169
2021
Q3
$20.7M Buy
167,377
+33,144
+25% +$4.27M 0.09% 215
2021
Q2
$16.1M Buy
134,233
+12,697
+10% +$1.45M 0.07% 270
2021
Q1
$12.8M Buy
121,536
+1,848
+2% +$187K 0.06% 284
2020
Q4
$12.2M Buy
119,688
+2,572
+2% +$242K 0.06% 281
2020
Q3
$9.85M Buy
117,116
+22,671
+24% +$1.76M 0.06% 281
2020
Q2
$6.13M Sell
94,445
-23,517
-20% -$1.55M 0.04% 385
2020
Q1
$7.68M Buy
117,962
+30,617
+35% +$2.41M 0.06% 304
2019
Q4
$6.88M Buy
87,345
+24,273
+38% +$1.89M 0.04% 375
2019
Q3
$5.02M Sell
63,072
-3,165
-5% -$249K 0.03% 423
2019
Q2
$5.54M Sell
66,237
-1,488
-2% -$119K 0.04% 420
2019
Q1
$5.35M Sell
67,725
-44,470
-40% -$3.25M 0.04% 430
2018
Q4
$7.49M Sell
112,195
-54,177
-33% -$3.75M 0.06% 321
2018
Q3
$13.3M Buy
166,372
+37,596
+29% +$2.81M 0.07% 274
2018
Q2
$8.68M Buy
128,776
+37,876
+42% +$2.75M 0.05% 349
2018
Q1
$6.99M Sell
90,900
-8,658
-9% -$640K 0.04% 409
2017
Q4
$6.79M Sell
99,558
-13,712
-12% -$910K 0.04% 453
2017
Q3
$7.09M Buy
113,270
+1,160
+1% +$69.3K 0.04% 456
2017
Q2
$6.21M Buy
112,110
+1,280
+1% +$66.7K 0.03% 499
2017
Q1
$5.57M Sell
110,830
-6,038
-5% -$294K 0.03% 541
2016
Q4
$5.79M Buy
116,868
+6,398
+6% +$324K 0.03% 519
2016
Q3
$5.79M Buy
110,470
+2,957
+3% +$145K 0.04% 507
2016
Q2
$4.8M Sell
107,513
-8,212
-7% -$357K 0.03% 528
2016
Q1
$4.73M Sell
115,725
-1,862
-2% -$68.6K 0.04% 503
2015
Q4
$4.29M Sell
117,587
-880
-0.7% -$31.8K 0.03% 541
2015
Q3
$3.89M Sell
118,467
-2,939
-2% -$98.9K 0.03% 562
2015
Q2
$4.5M Sell
121,406
-100,430
-45% -$3.65M 0.03% 552
2015
Q1
$7.77M Buy
221,836
+21,310
+11% +$752K 0.05% 399
2014
Q4
$7.63M Sell
200,526
-130
-0.1% -$4.75K 0.06% 365
2014
Q3
$7.12M Sell
200,656
-600
-0.3% -$22.3K 0.06% 377
2014
Q2
$7.87M Buy
201,256
+17,396
+9% +$650K 0.06% 351
2014
Q1
$6.7M Buy
183,860
+7,050
+4% +$257K 0.05% 378
2013
Q4
$6.12M Buy
176,810
+4,283
+2% +$138K 0.05% 388
2013
Q3
$4.82M Buy
172,527
+15,765
+10% +$420K 0.04% 428
2013
Q2
$4.22M Buy
+156,762
New +$4.33M 0.04% 398

Other funds holding XYL

Aviva's XYL Position: Q2 2026 in Review

Aviva reduced its Xylem (XYL) stake by 2.2% in Q2 2026, selling an estimated $3.02M and leaving 1,162,165 shares worth $137M. The position accounts for 0.2% of the portfolio, ranked #92.

Aviva first reported a position in XYL in Q2 2013 and has held it in 53 quarters since. The position peaked at $142M in Q1 2026. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Aviva held 1,162,165 shares of Xylem worth $137M as of Q2 2026.
  • Aviva sold 26,179 Xylem shares in Q2 2026, an estimated $3.02M.
  • Xylem made up 0.2% of Aviva's portfolio in Q2 2026, its #92 holding.
  • Aviva first reported a position in Xylem in Q2 2013 and has held it in 53 quarters since.
  • Aviva's Xylem position peaked at $142M in Q1 2026.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.